148 related articles for article (PubMed ID: 33310300)
1. Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma.
Ghirardelli P; Franceschini D; D'Aveni A; Dominici L; Ravasio A; Marzo M; Villa E; Di Noia V; Scorsetti M; Vavassori V; Ceresoli GL
Lung Cancer; 2021 Feb; 152():1-6. PubMed ID: 33310300
[TBL] [Abstract][Full Text] [Related]
2. Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
Fodor A; Broggi S; Incerti E; Dell'Oca I; Fiorino C; Samanes Gajate AM; Pasetti M; Cattaneo MG; Passoni P; Gianolli L; Calandrino R; Picchio M; Di Muzio N
Clin Lung Cancer; 2019 Jan; 20(1):e29-e38. PubMed ID: 30253920
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy.
Schröder C; Opitz I; Guckenberger M; Stahel R; Weder W; Förster R; Andratschke N; Lauk O
Front Oncol; 2019; 9():961. PubMed ID: 31616640
[No Abstract] [Full Text] [Related]
4. Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience.
Franceschini D; De Rose F; Cozzi S; Renna I; Franzese C; Di Brina L; Navarria P; D'Agostino GR; Mancosu P; Tomatis S; Scorsetti M
Clin Lung Cancer; 2020 Jan; 21(1):86-93. PubMed ID: 31563545
[TBL] [Abstract][Full Text] [Related]
5. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
Minatel E; Trovo M; Polesel J; Baresic T; Bearz A; Franchin G; Gobitti C; Rumeileh IA; Drigo A; Fontana P; Pagan V; Trovo MG
Lung Cancer; 2014 Jan; 83(1):78-82. PubMed ID: 24216141
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.
Bayman N; Appel W; Ashcroft L; Baldwin DR; Bates A; Darlison L; Edwards JG; Ezhil V; Gilligan D; Hatton M; Jegannathen A; Mansy T; Peake MD; Pemberton L; Rintoul RC; Snee M; Ryder WD; Taylor P; Faivre-Finn C
J Clin Oncol; 2019 May; 37(14):1200-1208. PubMed ID: 30920878
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma.
Matsuo Y; Shibuya K; Okubo K; Ueki N; Aoyama A; Sonobe M; Nakamura M; Mizowaki T; Date H; Hiraoka M
Acta Oncol; 2017 Jul; 56(7):957-962. PubMed ID: 28117611
[TBL] [Abstract][Full Text] [Related]
8. Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesothelioma.
Arrieta O; Lozano-Ruiz F; Blake-Cerda M; Catalán R; Lara-Mejía L; Salinas MÁ; Maldonado-Magos F; Corona-Cruz JF
Thorac Cancer; 2020 Dec; 11(12):3448-3455. PubMed ID: 33030313
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesothelioma.
Simon M; Shochat T; Peled N; Zer A; Kramer MR; Eldan O; Saute M; Dudnik ER; Allen AM
Thorac Cancer; 2018 Nov; 9(11):1470-1475. PubMed ID: 30240138
[TBL] [Abstract][Full Text] [Related]
10. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
[TBL] [Abstract][Full Text] [Related]
11. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
[TBL] [Abstract][Full Text] [Related]
12. STEREOTACTIC BODY RADIATION THERAPY FOR OLIGO-PROGRESSIVE PLEURAL MESOTHELIOMA: FINE-TUNING THE OPTIMAL DOSES.
Ghirardelli P; Costantino G; Franceschini D; Villa E; Guaineri A; Scorsetti M; Vavassori V; Ceresoli GL
Pract Radiat Oncol; 2024 May; ():. PubMed ID: 38815652
[TBL] [Abstract][Full Text] [Related]
13. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
[TBL] [Abstract][Full Text] [Related]
14. Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases.
Clive AO; Wilson P; Taylor H; Morley AJ; de Winton E; Panakis N; Rahman N; Pepperell J; Howell T; Batchelor TJ; Jordan N; Lee YC; Dobson L; Maskell NA
BMJ Open; 2015 Jan; 5(1):e006673. PubMed ID: 25575875
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma.
Marulli G; Faccioli E; Bellini A; Mammana M; Rea F
Expert Rev Respir Med; 2017 Aug; 11(8):649-660. PubMed ID: 28580813
[TBL] [Abstract][Full Text] [Related]
17. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Zucali PA; Perrino M; Lorenzi E; Ceresoli GL; De Vincenzo F; Simonelli M; Gianoncelli L; De Sanctis R; Giordano L; Santoro A
Lung Cancer; 2014 Jun; 84(3):265-70. PubMed ID: 24321581
[TBL] [Abstract][Full Text] [Related]
19. Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma.
Kostron A; Friess M; Crameri O; Inci I; Schneiter D; Hillinger S; Stahel R; Weder W; Opitz I
Eur J Cardiothorac Surg; 2016 May; 49(5):1516-23. PubMed ID: 26590183
[TBL] [Abstract][Full Text] [Related]
20. Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.
Jhavar S; Pruszynski J; Gowan A; Boyle T; Deb N; Patel M
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e88-e94. PubMed ID: 28371288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
